Cercar
01/10/2024
Efficacy of Food Industry By-Product ß-Glucan/Chitin-Chitosan on Lipid Profile of Overweight and Obese Individuals: Sustainability and Nutraceuticals
Santisteban, V, Muñoz-Garcia, N, López-Yerena, A, Puntes, M, Badimon, L, Padro, T. Efficacy of Food Industry By-Product ß-Glucan/Chitin-Chitosan on Lipid Profile of Overweight and Obese Individuals: Sustainability and Nutraceuticals. Nutrients. 2024; 16(19)DOI:10.3390/nu16193420. PMID:39408385. IF:5.000(Q1/2D).
01/10/2024
Understanding sex-based differences by adverse events
Perelló, PM, Hurtado, JC, Rodríguez, MP, Arbós, RMA. Understanding sex-based differences by adverse events. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135DOI:. PMID:. IF:3.300(Q2/4D).
01/10/2024
Effectiveness, adequacy and costs of the antibiotic treatment in adult patients with non-cystic fibrosis bronchiectasis and primary infection by Pseudomonas aeruginosa
Espinoza, CED, Carrillo, DLR, Simonetti, AF, Pereyra, FG, De Andrade, FC, Schlegel, PA, Ysasis, YM, Reus, FSA, Pestana, MJC, Arbos, RMA. Effectiveness, adequacy and costs of the antibiotic treatment in adult patients with non-cystic fibrosis bronchiectasis and primary infection by Pseudomonas aeruginosa. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135DOI:. PMID:. IF:3.300(Q2/4D).
01/10/2024
Drug-induced liver injury (DILI) due anakinra in adult-onset Still's disease (AOSD): Two case reports and review
Pestana, MJC, Hosey, KCA, Arbós, RA. Drug-induced liver injury (DILI) due anakinra in adult-onset Still's disease (AOSD): Two case reports and review. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135DOI:. PMID:. IF:3.300(Q2/4D).